open access

Vol 91, No 8 (2020)
ORIGINAL PAPERS Gynecology
Published online: 2020-08-31
Get Citation

Ultrasound guided percutaneous radiofrequency thermal ablation of symptomatic uterine fibroids — results from a single center and 52 weeks of follow up

Gokhan Yüce, Aybuke Tayarer, Hüseyin Levent Keskin, Birgül Genc, Murat Canyigit
DOI: 10.5603/GP.2020.0074
·
Pubmed: 32902841
·
Ginekol Pol 2020;91(8):447-452.

open access

Vol 91, No 8 (2020)
ORIGINAL PAPERS Gynecology
Published online: 2020-08-31

Abstract

Objectives: Uterine fibroids are one of the most common female disorder of the reproductive age and may cause abnormal uterine bleeding (UAB), pain or infertility. Our aim was to evaluate the safety and efficacy of percutaneous radio frequency ablation (RFA) in reducing clinical symptoms, fibroid volume and improving laboratory parameters.
Material and methods: Thirty-five symptomatic patients with 54 uterine fibroids were enrolled. Preintervention evaluation was made for each participant and included ultrasonography to assess the volume, largest diameter and location of the fibroid and Visual Analogue Scale (VAS) for quantifying the degree of menstrual pain. The magnitude of menstrual bleeding was scored for each patient by using pictogram. Preprocedural laboratory assessment included hemoglobulin and hematocrit. Treatment efficacy was evaluated at 3, 6 and 12 months after the intervention with ultrasound (US) measurements,
symptom scores and laboratory parameters.
Results: Pretreatment mean Hb was significantly lower than those at 3, 6 and 12 month post treatment visits (p < 0.001). The pretreatment median volume was significantly higher than the median volumes measured at 3, 6 and 12 months after RFA (p < 0.001). Visual Analogue Score (VAS) for pain was significantly lower than baseline values at 6 and 12 month visits (p < 0.01). Pretreatment bleeding scores and the number of patients in the predefined severe bleeding category were significantly decreased.
Conclusions: US guided RF ablation of uterine fibroids is relatively safe and effective procedure. It can be applied to the fibroids with varying localizations and sizes. It reduces the fibroid volume and obviate a need for more invasive treatment.

Abstract

Objectives: Uterine fibroids are one of the most common female disorder of the reproductive age and may cause abnormal uterine bleeding (UAB), pain or infertility. Our aim was to evaluate the safety and efficacy of percutaneous radio frequency ablation (RFA) in reducing clinical symptoms, fibroid volume and improving laboratory parameters.
Material and methods: Thirty-five symptomatic patients with 54 uterine fibroids were enrolled. Preintervention evaluation was made for each participant and included ultrasonography to assess the volume, largest diameter and location of the fibroid and Visual Analogue Scale (VAS) for quantifying the degree of menstrual pain. The magnitude of menstrual bleeding was scored for each patient by using pictogram. Preprocedural laboratory assessment included hemoglobulin and hematocrit. Treatment efficacy was evaluated at 3, 6 and 12 months after the intervention with ultrasound (US) measurements,
symptom scores and laboratory parameters.
Results: Pretreatment mean Hb was significantly lower than those at 3, 6 and 12 month post treatment visits (p < 0.001). The pretreatment median volume was significantly higher than the median volumes measured at 3, 6 and 12 months after RFA (p < 0.001). Visual Analogue Score (VAS) for pain was significantly lower than baseline values at 6 and 12 month visits (p < 0.01). Pretreatment bleeding scores and the number of patients in the predefined severe bleeding category were significantly decreased.
Conclusions: US guided RF ablation of uterine fibroids is relatively safe and effective procedure. It can be applied to the fibroids with varying localizations and sizes. It reduces the fibroid volume and obviate a need for more invasive treatment.

Get Citation

Keywords

uterine fibroids; percutaneous; radiofrequency ablation

Supplementary Files (4)
Untitled
View
482KB
Untitled
View
400KB
Untitled
View
524KB
Untitled
View
507KB
About this article
Title

Ultrasound guided percutaneous radiofrequency thermal ablation of symptomatic uterine fibroids — results from a single center and 52 weeks of follow up

Journal

Ginekologia Polska

Issue

Vol 91, No 8 (2020)

Pages

447-452

Published online

2020-08-31

DOI

10.5603/GP.2020.0074

Pubmed

32902841

Bibliographic record

Ginekol Pol 2020;91(8):447-452.

Keywords

uterine fibroids
percutaneous
radiofrequency ablation

Authors

Gokhan Yüce
Aybuke Tayarer
Hüseyin Levent Keskin
Birgül Genc
Murat Canyigit

References (21)
  1. Baird DD, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003; 188(1): 100–107.
  2. Cardozo ER, Clark AD, Banks NK, et al. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012; 206(3): 211.e1–211.e9.
  3. Ierardi AM, Savasi V, Angileri SA, et al. Percutaneous High Frequency Microwave Ablation of Uterine Fibroids: Systematic Review. Biomed Res Int. 2018; 2018: 2360107.
  4. Kim CH, Kim SR, Lee HA, et al. Transvaginal ultrasound-guided radiofrequency myolysis for uterine myomas. Hum Reprod. 2011; 26(3): 559–563.
  5. Bulun SE. Uterine fibroids. N Engl J Med. 2013; 369(14): 1344–1355.
  6. Jones S, O'Donovan P, Toub D. Radiofrequency ablation for treatment of symptomatic uterine fibroids. Obstet Gynecol Int. 2012; 2012: 194839.
  7. Woźniak A, Woźniak S. Ultrasonography of uterine leiomyomas. Prz Menopauzalny. 2017; 16(4): 113–117.
  8. Guarnaccia MM, Rein MS. Traditional surgical approaches to uterine fibroids: abdominal myomectomy and hysterectomy. Clin Obstet Gynecol. 2001; 44(2): 385–400.
  9. Recaldini C, Carrafiello G, Laganà D, et al. Percutaneous sonographically guided radiofrequency ablation of medium-sized fibroids: feasibility study. AJR Am J Roentgenol. 2007; 189(6): 1303–1306.
  10. Kroon B, Johnson N, Chapman M, et al. Australasian CREI Consensus Expert Panel on Trial evidence (ACCEPT) group. Fibroids in infertility--consensus statement from ACCEPT (Australasian CREI Consensus Expert Panel on Trial evidence). Aust N Z J Obstet Gynaecol. 2011; 51(4): 289–295.
  11. Carrafiello G, Recaldini C, Fontana F, et al. Ultrasound-guided radiofrequency thermal ablation of uterine fibroids: medium-term follow-up. Cardiovasc Intervent Radiol. 2010; 33(1): 113–119.
  12. Lee BB, Yu SP. Radiofrequency Ablation of Uterine Fibroids: a Review. Curr Obstet Gynecol Rep. 2016; 5(4): 318–324.
  13. Ludwig PE, Huff TJ, Shanahan MM, et al. Pregnancy success and outcomes after uterine fibroid embolization: updated review of published literature. Br J Radiol. 2020; 93(1105): 20190551.
  14. Garza Leal JG, Hernandez Leon I, Castillo Saenz L, et al. Laparoscopic ultrasound-guided radiofrequency volumetric thermal ablation of symptomatic uterine leiomyomas: feasibility study using the Halt 2000 Ablation System. J Minim Invasive Gynecol. 2011; 18(3): 364–371.
  15. Kim HS, Tsai J, Jacobs MA, et al. Percutaneous image-guided radiofrequency thermal ablation for large symptomatic uterine leiomyomata after uterine artery embolization: a feasibility and safety study. J Vasc Interv Radiol. 2007; 18(1 Pt 1): 41–48.
  16. Bergamini V, Ghezzi F, Cromi A, et al. Laparoscopic radiofrequency thermal ablation: a new approach to symptomatic uterine myomas. Am J Obstet Gynecol. 2005; 192(3): 768–773.
  17. Ghezzi F, Cromi A, Bergamini V, et al. Midterm outcome of radiofrequency thermal ablation for symptomatic uterine myomas. Surg Endosc. 2007; 21(11): 2081–2085.
  18. Zhang J, Feng L, Zhang B, et al. Ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroid treatment--a clinical study. Int J Hyperthermia. 2011; 27(5): 510–516.
  19. Chudnoff SG, Berman JM, Levine DJ, et al. Outpatient procedure for the treatment and relief of symptomatic uterine myomas. Obstet Gynecol. 2013; 121(5): 1075–1082.
  20. Levens ED, Wesley R, Premkumar A, et al. Magnetic resonance imaging and transvaginal ultrasound for determining fibroid burden: implications for research and clinical care. Am J Obstet Gynecol. 2009; 200(5): 537.e1–537.e7.
  21. Turtulici G, Orlandi D, Dedone G, et al. Ultrasound-guided transvaginal radiofrequency ablation of uterine fibroids assisted by virtual needle tracking system: a preliminary study. Int J Hyperthermia. 2019; 35(1): 97–104.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl